Meanings of prostate-specific antigen testing as narrated by men with localized prostate cancer after primary treatment

被引:6
|
作者
Hedestig, Oliver [1 ]
Sandman, Per-Olof [1 ]
Widmark, Anders [2 ]
Rasmussen, Birgit H. [1 ]
机构
[1] Umea Univ, Dept Nursing, S-90185 Umea, Sweden
[2] Umea Univ, Dept Radiat Sci, S-90185 Umea, Sweden
来源
关键词
D O I
10.1080/00365590701571530
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective. To illuminate the meanings of prostate-specific antigen (PSA) testing as narrated by men with localized prostate cancer (LPC) after primary treatment. Material and methods. Fifteen men were interviewed in their homes. The narrative interview text was analyzed using a phenomenological hermeneutic method inspired by the philosophy of Paul Ricoeur. Results. Life after treatment for LPC means feeling unsafe because of being affected by a life-threatening and unpredictable disease, characterized by a lack of early signs of progression. In this situation, PSA testing is ascribed as providing a sense of control to enable one to achieve a feeling of safety. Thus one meaning of PSA testing is receiving a message about the status of the body; another is a tense waiting related to fear of the results. A low, stable PSA value is interpreted as a sense of being safe based on confidence in the PSA tests and a sense of having control over the LPC via regular PSA testing. A rising value of the PSA blood test is understood as an indication of progression of the disease, but confidence in PSA testing also means that when the PSA value rises there is a sense of catching the cancer in good time. Conclusions. The comprehensive understanding of the meaning of PSA testing can be understood in terms of a lifeline to cling to when wondering whether the cancer is still in progress in the body or whether the treatment has been curative. This lifeline creates a feeling of security in a post-treatment life situation which is experienced as being unsafe.
引用
收藏
页码:101 / 109
页数:9
相关论文
共 50 条
  • [1] Posttreatment Prostate-Specific Antigen Surveillance After Primary Treatment of Prostate Cancer
    Luh, Join Y.
    Harmon, Michael W.
    Eng, Tony Y.
    [J]. MAYO CLINIC PROCEEDINGS, 2013, 88 (03) : 307 - 308
  • [2] Trajectories of prostate-specific antigen after treatment for prostate cancer
    Wu, Ziyue
    Aslan, Mihaela
    Lin, Haiqun
    Ko, John
    Radhakrishnan, Krishnan
    Wells, Carolyn K.
    Uchio, Edward
    Concato, John
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2018, 66 (04) : 768 - 772
  • [3] Posttreatment Prostate-Specific Antigen Surveillance After Primary Treatment of Prostate Cancer reply
    Tilburt, Jon C.
    Kim, Simon
    Kohli, Manish
    Nahbhan, Mohammed
    [J]. MAYO CLINIC PROCEEDINGS, 2013, 88 (03) : 308 - 308
  • [4] Access to Prostate-Specific Antigen Testing and Mortality Among Men With Prostate Cancer
    Iyer, Hari S.
    Stone, Benjamin V.
    Roscoe, Charlotte
    Hsieh, Mei-Chin
    Stroup, Antoinette M.
    Wiggins, Charles L.
    Schumacher, Fredrick R.
    Gomez, Scarlett L.
    Rebbeck, Timothy R.
    Trinh, Quoc-Dien
    [J]. JAMA NETWORK OPEN, 2024, 7 (06)
  • [5] Changing prostate-specific antigen outcome after surgery or radiotherapy for localized prostate cancer during the prostate-specific antigen era
    D'Amico, AV
    Chen, MH
    Oh-Ung, J
    Renshaw, AA
    Cote, K
    Loffredo, M
    Richie, JP
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2002, 54 (02): : 436 - 441
  • [6] Limitations of Prostate-specific Antigen Testing After a Prostate Cancer Diagnosis
    Caram, Megan E. V.
    Skolarus, Ted A.
    Cooney, Kathleen A.
    [J]. EUROPEAN UROLOGY, 2016, 70 (02) : 209 - 210
  • [7] The use of prostate-specific antigen and free/total prostate-specific antigen in the diagnosis of localized prostate cancer
    Partin, AW
    Carter, HB
    [J]. UROLOGIC CLINICS OF NORTH AMERICA, 1996, 23 (04) : 531 - +
  • [8] Rising prostate-specific antigen after primary prostate cancer therapy
    Ward, JF
    Moul, JW
    [J]. NATURE CLINICAL PRACTICE UROLOGY, 2005, 2 (04): : 174 - 182
  • [9] Rising prostate-specific antigen after primary prostate cancer therapy
    John F Ward
    Judd W Moul
    [J]. Nature Clinical Practice Urology, 2005, 2 : 174 - 182
  • [10] Prostate-specific antigen testing of older men
    Carter, HB
    Landis, PK
    Metter, EJ
    Fleisher, LA
    Pearson, JD
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (20) : 1733 - 1737